Atlas Trials

Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection

Clinical trial NCT03158077 · COMPLETED

Trial details

NCT number
NCT03158077
Sponsor
Fundacion SEIMC-GESIDA
Status
COMPLETED
Study type
OBSERVATIONAL
HIV Infections
Start date
2016-11-15
Primary completion
2017-04-20
Enrollment
467

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.